Breaking News Instant updates and real-time market news.

Piper Jaffray analyst Erinn Murphy says her work year-to-date indicates generally well controlled inventory across the domestic athletic industry. Currently, Under Armour (UAA) online clearance styles are down 19% year-over-year versus Nike's (NKE) down 5% and Adidas' (ADDYY) up 96%. The analyst believes industry competition "should remain rational" during 2019. Further, Q1 consensus expectations for Under Armour are "at least achievable" and management should maintain fiscal 2019 guidance, Murphy tells investors in a pre-earnings research note. The analyst this quarter has seen on-going traction with HOVR's footwear platform, broader focus with Under Armour's women's and a well-supported launch of Rush. She keeps an Overweight rating on Under Armour shares with a $30 price target.

B. Riley FBR analyst Susan Anderson says her firm's annual athletic footwear/apparel survey showed that Under Armour (UAA) continues to lag behind competitors across basketball, running, and casual footwear and athletic apparel. Respondents placed Under Armour behind brands such as New Balance and Puma, in addition to Nike (NKE) and Adidas (ADDYY), which maintained the number one and two spots in this year's survey, Anderson tells investors in a research note. She keeps a Sell rating on Under Armour with a $12 price target.

04/10/19

SBSH

04/10/19UPGRADETarget $29SBSHBuy

Under Armour assumed with a Buy from Neutral at Citi

Citi analyst Paul Lejuez assumed coverage of Under Armour (UAA) from Kate McShane and upgraded the shares to Buy from Neutral. He raised his price target for the stock to $29 from $23. Under Armour is "growing up" with a renewed focus on driving profitability and return on invested capital, Lejuez tells investors in a research note. With just a 3.4% EBIT margin in 2018, the company has the opportunity to recapture 600 basis points in EBIT margin over the next several years, says the analyst. And near-term, Lejuez sees upside to management's fiscal 2019 gross margin guidance.

04/10/19

04/10/19UPGRADE

Fly Intel: Top five analyst upgrades

Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. First Solar (FSLR) upgraded to Conviction Buy from Buy at Goldman Sachs with analyst Brian Lee citing his view on two potential company-specific catalysts. 2. Disney (DIS) upgraded to Outperform from Market Perform at BMO Capital with analyst Daniel Salmon saying with tomorrow's investor day, two Star Wars-themed lands opening in the domestic parks this summer, the launch of streaming service Disney+ before year-end, and a potential re-start of the buyback program within 12 months, Disney shares now have catalysts to go along with downside protection. 3. Under Armour (UA, UAA) assumed with a Buy from Neutral at Citi with analyst Paul Lejuez saying Under Armour is "growing up" with a renewed focus on driving profitability and return on invested capital. 4. KB Home (KBH) upgraded to Neutral from Underweight at JPMorgan with analyst Michael Rehaut saying the ongoing shift towards smaller-sized first-time product and double-digit community count growth should drive "above average fundamentals" in fiscal 2019 for KB Home. 5. Nordstrom (JWN) upgraded to Overweight from Sector Weight at KeyBanc with analyst Edward Yruma saying recent meetings with co-CEO Erik Nordstrom and CFO Anne Bramman affirm that the company is prepared to transition its asset base as e-commerce continues to grow. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

04/12/19

JEFF

04/12/19NO CHANGEJEFF

Under Armour discounts flat to down for 12th straight month, says Jefferies

Jefferies analyst Randal Konik says his firm's March webscrapes illustrate that Under Armour's (UAA) percentage of product on discount is flat to down for the twelfth month in a row year-over-year, Jefferies analyst Randal Konik tells investors in a research note. Further, the webscrapes show Adidas's (ADDYY) percentage of product on discount is up for the twelfth month in a row year-over-year, adds the analyst. In addition, visits to Finish Line (FINL), Foot Locker (FL), and Under Armour websites reveal the HOVR, Project Rock, and Curry 6 are sold out in several sizes, indicating strong demand, says Konik. He believes Nike (NKE) continues to dominate Adidas in running in the U.S., with strength in Air VaporMax and Air Max 270. The analyst also thinks the data bodes well for Under Armour's's sales and margins in Q1.

UAUnder Armour

$19.66

0.19 (0.98%)

NKENike

$88.74

0.84 (0.96%)

04/10/19

SBSH

04/10/19INITIATIONTarget $100SBSHBuy

Nike assumed with a Buy rating, $100 price target at Citi

Citi analyst Paul Lejuez assumed coverage of Nike from Kate McShane and kept a Buy rating on the shares. He raised his price target for the stock to $100 from $96. Nike is the dominant player in the global athletic footwear and apparel market, which is a "healthy and growing market buoyed by structural tailwinds," Lejuez tells investors in a research note.

04/10/19

SBSH

04/10/19DOWNGRADETarget $68SBSHNeutral

Foot Locker assumed with a Neutral from Buy at Citi

Citi analyst Paul Lejuez assumed coverage of Foot Locker (FL) from Kate McShane and downgraded the shares to Neutral from Buy. He also lowered his price target for the stock to $68 from $72. While Foot Locker has "tailwinds at its back" in North America with comps inflecting positively in Q4, the company still faces many of the same headwinds as other specialty retailers given its "significant" mall exposure and EBIT pressure from direct-to-consumer, Lejuez tells investors in a research note. He believes Nike's direct-to-consumer ambitions are a "secular headwind" for Foot Locker.

ADDYYAdidas

$0.00

(0.00%)

02/25/19

02/25/19UPGRADE

Fly Intel: Top five analyst upgrades

Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Norwegian Cruise Line (NCLH) upgraded to Outperform from Neutral at Macquarie. 2. Brunswick (BC) upgraded to Overweight from Neutral at JPMorgan by analyst Steven Zaccone, who said that following recent "encouraging" data points on the marine industry, macro backdrop, and company-specific growth drivers, the setup is more favorable to own Brunswick in 2019. 3. UGI Corporation (UGI) upgraded to Buy from Neutral at UBS by analyst Shneur Gershuni, who said the 8% selloff since mid-December is an overreaction to the company's recent Q1 miss on the back of warm weather. The analyst believes UGI's strategic review of AmeriGas (APU) could "substantially increase" the company's cash flow and market capitalization if a roll-up is the outcome.4. Infinera (INFN) upgraded to Neutral from Sell at MKM Partners by analyst Michael Genovese, who said the company's commentary about new bookings was better than he expected. Genovese also noted that management's view of significant backlog growth in Q4 and expectations for another increase in Q1, but warned that there is still "significant risk" to Infinera's 2019 revenue outlook being a "high hurdle." 5. Adidas (ADDYY) upgraded to Outperform from Market Perform at Wells Fargo by analyst Tom Nikic, who said his math suggests a greater-than-expected contribution from the long-awaited democratization of the Yeezy sub-brand. The company seems to have hit a ''lull'' on new product launches for the core brand and faces headwinds from the 2018 World Cup through Q2 of 2019, but Nikic believes these challenges are well understood by investors, and the ''opening the faucet'' on the Yeezy brand can get Adidas through these 2019 challenges and allow for a ''soft landing'' on the top line in 2019. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

03/14/19

MSCO

03/14/19NO CHANGETarget $103MSCOOverweight

Morgan Stanley sees Q3 EPS beat coming from Nike

Morgan Stanley analyst Lauren Cassel previewed Nike's (NKE) Q3 report, stating that she expects an EPS beat and a high-single digit constant currency revenue growth forecast for FY20 coming from the company. Adidas' (ADDYY) Q4 sales ex-Reebok were notably softer in North America on a constant currency basis, noted Cassel, who reads this as a sign that its share losses are accelerating. She maintains an Overweight rating and $103 price target on Nike ahead of the company's Q3 earnings report on Thursday, March 21.

According to a regulatory filing, Ryan Graves informed Uber Technologies of his intention to resign as a member of the company's board of directors, effective as of May 27, 2019, including any committees of the board of directors on which he serves. Graves' resignation was not the result of any disagreement between Graves and the company, its management, board of directors or any committee thereof, or with respect to any matter relating to the company's operations, policies or practices, according to the filing.

U.S. Energy announced that on May 21, Nasdaq notified the company that as a result of not having received its Quarterly Report on Form 10-Q for the period ended March 31. 2019, and because the company is delinquent in filing its Form 10-K for the year ended December 31, 2018, the company does not comply with the requirements of Nasdaq Listing Rule 5250(c)(1) for continued listing on the Exchange. This notification has no effect on the listing of the company's common stock at this time. However, pursuant to the notice, the company was required to submit a plan by May 23, 2019 to comply with the Exchange's requirements for continued listing.

Apple is being sued by customers alleging that the U.S. tech giant is unlawfully disclosing and selling information about users' iTunes purchases as well as their personal data, Bloomberg's Robert Burnson reports. The customers claim that such alleged practices are contrary to Apple's promise in advertising that "What happens on your iPhone stays on your iPhone," Burnson notes. Reference Link

SuperCom received a notification from Nasdaq for not having timely filed its Annual Report on Form 20-F for the year ended December 31, 2018, as previously disclosed by the company on May 16, 2019. The company does not comply with the Nasdaq Listing Rule 5250(c)(1). This notice from Nasdaq has no effect currently on the listing of the company's common stock on the Nasdaq Capital Market.

U.S. Energy announced that Nasdaq notified the company that as a result of not having received the company's quarterly report on Form 10-Q for the period ended March 31 and because the company is delinquent in filing its Form 10-K for the year ended December 31, 2018, the company does not comply with the requirements of Nasdaq Listing Rule 5250 for continued listing on the exchange. This notification has no effect on the listing of the company's common stock at this time. However, pursuant to the notice, the company was required to submit a plan by May 23 to comply with the exchange's requirements for continued listing. The company has submitted the plan to the exchange. If the exchange accepts the company's Plan, the exchange may grant an exception of up to 180 calendar days from the Form 10-K's due date, or until October 14 to regain compliance. The company continues to work toward the filing of the Form 10-Q and the Form 10-K with the SEC as soon as practicable.

Qiagen (QGEN) announced the launch of its therascreen PIK3CA RGQ PCR Kit after it received U.S. regulatory approval as a companion diagnostic to aid in identifying breast cancer patients eligible for treatment with PIQRAY, a newly approved therapy developed and marketed by Novartis (NVS). The therascreen PIK3CA Kit is the first companion diagnostic assay to obtain premarket approval from the FDA for use in any cancer indication for detection of activating mutations in the PIK3CA gene. It is also the first FDA approved assay for guiding treatment decisions in breast cancer using plasma specimens as a liquid biopsy.

Brazil's ANAC said it has suspended all flights and operations of Avianca Brasil in the South American nation as a precuartionary measure, Reuters reports. The move follows Avianca's filing for bankruptcy in late 2018, the report says. "All the flights are suspended until the company proves it has the capacity to maintain operations safely," ANAC said. Reference Link

Apple has bought Tueo Health, a start-up that was making a system to help parents monitor asthma symptoms in sleeping kids, CNBC's Christina Farr and Steve Kovach report, citing a person familiar with the deal. It is not clear how much the U.S. tech giant paid for the start-up, the authors note. Reference Link

A review of Boeing's grounded 737 MAX aircraft has expanded to include emergency procedures used by pilots on earlier models of the plane, further delaying its return to service, the Wall Street Journal's Andy Pasztor reports, citing U.S. government officials. The FAA hasn't questioned the safety of older aircraft currently in service, but the broadened review will play a major role in adding months to the time expected to get the grounded fleet of 737 MAX jets back in the skies, Pasztor notes. As part of the FAA's safety analysis of a proposed software fix for the fleet, the agency is also weighing changes to how pilots of the entire 737 family are trained to respond when the flight-control computer or other systems suddenly push the jet's nose down, the author says. Reference Link

The CBOE Volatility Index (VIX), the SPX option derived measure of implied volatility, fell 1.07 today to close at 15.85, while the underlying SPX index gained 3.82 to close at $2826.06, a 0.14% increase. 274,267 VIX option contracts traded, 38.73% of the typical daily volume for the product. Calls made up 74.0% of the volume.

Volume was average for this time of day. Breadth was mixed with issues and volume bullish while new highs to new lows were bearish (negative divergence). Advancing Issues: 2009 / Declining Issues: 1048 -- for a ratio of 1.9 to 1. Advancing Volume: 915,942,000 / Declining Volume: 681,710,000 -- for a ratio of 1.3 to 1. New 52-Week Highs: 57 / New 52-Week Lows: 114.

Volume was below average for this time of day. Breadth was bullish across the board. Advancing Issues: 1963 / Declining Issues: 956 -- for a ratio of 2.1 to 1. Advancing Volume: 1,549,354,000 / Declining Volume: 986,891,000 -- for a ratio of 1.6 to 1. New 52-Week Highs: 138 / New 52-Week Lows: 89.

Regional Health Properties, Inc. announcement concerning the company's noncompliance with the continued listing standards of NYSE American LLC. On May 21, 2019, the company received an official notice of noncompliance from the Exchange stating that the company is not in compliance with the Exchange's continued listing standards under the timely filing criteria outlined in Section 1007 of the Exchange's company Guide because the company failed to timely file its Quarterly Report on Form 10-Q for the period ended March 31, 2019, which was due to be filed with the Securities and Exchange Commission no later than May 20, 2019. For the reasons previously disclosed in its Form 12b-25 filed with the Securities and Exchange Commission on May 16, 2019, the company has not timely filed the Delayed Form 10-Q because additional time is needed to finalize the Delayed Form 10-Q and furnish the XBRL Interactive Data File exhibits required by Item 601b101 of Regulation S-K. The company is actively working to complete the Delayed Form 10-Q and intends to file the Delayed Form 10-Q under the Securities Exchange Act of 1934, as amended, within the next thirty days. As a result of the foregoing, the company has become subject to the procedures and requirements of Section 1007 of the Company Guide. During the six-month period from the date of the Filing Delinquency, the Exchange will monitor the company and the status of the Delayed Form 10-Q and any subsequent reports until the Filing Delinquency is cured. If the company fails to cure the Filing Delinquency within the Initial Cure Period, the Exchange may, in its sole discretion, allow the company's securities to be traded for up to an additional six-month period, depending on the company's specific circumstances. If the Exchange determines that an Additional Cure Period is not appropriate, suspension and delisting procedures will commence in accordance with the procedures set forth in Section 1010 of the Company Guide.